2nd Annual Midwest Metabolic Clinical Symposium

Add to Calendar 2nd Annual Midwest Metabolic Clinical Symposium 4/19/2024 7:30:00 AM 4/21/2024 12:00:00 PM America/Chicago For More Details: https://slu.cloud-cme.com/course/courseoverview?P=0&EID=13173 Description: The conference sessions will focus on current and emerging best practices for the management of obesity, diabetes, non-alcoholic fatty liver disease, and cardiovascular disease: - Rising incidence and prevalence of Obesity and T2DM - Parallel increase in prevalence of NAFLD; up to 40% of the US population affected - Introducing current and new treatment strategies to address these multiple overlappin... Hyatt false MM/DD/YYYY


Friday, April 19, 2024, 7:30 AM - Sunday, April 21, 2024, 12:00 PM, Hyatt, St. Louis, MO




The conference sessions will focus on current and emerging best practices for the management of obesity, diabetes, non-alcoholic fatty liver disease, and cardiovascular disease: - Rising incidence and prevalence of Obesity and T2DM - Parallel increase in prevalence of NAFLD; up to 40% of the US population affected - Introducing current and new treatment strategies to address these multiple overlapping disorders (with common pathogenic mechanisms) - Pediatric Metabolic Diseases - Polycystic Ovary Syndrome - Impact of metabolic disorders on Renal outcomes - Impact of metabolic diseases on COVID outcomes These conditions are seen by all physicians and are often not captured or under-diagnosed. Our aim is to bring attention to these common disorders and need for early identification of those at highest risk.



Objectives
  1. List metabolic risk factors
  2. Summarize the interactions of metabolic disorders with various organ systems including the kidneys, lung, heart, brain, ovaries, liver, skin
  3. Identify complications of the metabolic syndrome
  4. Discuss Weight Loss Strategies (medication, endoscopy, surgery)
  5. Review new medications for T2DM including GLP1 agonists, SGLT2 inhibitors, and DPP4 inhibitor
  6. Discuss new drugs to treat T2DM, including GLP1 agonists, SGLT2 inhibitors, and DPP4 inhibitors
  7. Recognize the impact of the Metabolic syndrome in the Pediatric population


Accreditation:

Saint Louis University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. 

Credit Designation:

Saint Louis University School of Medicine designates this live activity for a maximum of 14.00 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity. 

Saint Louis University School of Medicine will provide Other learner certificates (APPs, nurses, and other types of learners).  The certificate will state that the activity was designated for 14.00 AMA PRA Category 1 Credits™.  Follow your board's requirements for reciprocal CE credits.